TAT Technologies CEO reports shares and options stake

TAT Technologies Chief Executive Officer Igal Zamir reported his equity position in the company.

Rhea-AI Filing Summary

TAT Technologies Chief Executive Officer Igal Zamir reported his equity position in the company. He directly holds 21,386 Ordinary Shares. In addition, he holds stock options over 150,000 Ordinary Shares and a separate grant over 50,000 Ordinary Shares, each with an exercise price of 29.93 per share and expirations in March 2032 and August 2032, respectively. These options were granted in March 2025 and August 2025 and vest over several years, with initial tranches vesting in March 2026 and August 2026 and additional portions vesting every three months through 2029, subject to his continued employment.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Zamir Igal

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Stock Options (right to buy)	--	--	--
holding	Stock Options (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options (right to buy) — 200,000 contracts (Direct); Ordinary Shares — 21,386 shares (Direct)

Footnotes (2)

1. F1. The stock options were granted on March 20, 2025. 37,500 options vest on March 20, 2026; and the remaining options vest in installments of 9,375 every three months beginning on June 20, 2026 through March 20, 2029, subject to the Reporting Person's continued employment with the Issuer through each such vesting date.
2. F2. The stock options were granted on August 1, 2025. 12,500 options vest on August 1, 2026; and the remaining options vest in installments of 9,375 every three months beginning on August 1, 2026 through August 1, 2029, subject to the Reporting Person's continued employment with the Issuer through each such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity holdings does TAT Technologies (TATT) CEO Igal Zamir report?

Igal Zamir reports direct ownership of 21,386 Ordinary Shares of TAT Technologies. He also holds stock options covering 200,000 Ordinary Shares in total, split into two grants that vest over time and expire in 2032.

How many stock options over TAT Technologies (TATT) shares does the CEO hold?

The CEO holds stock options over 150,000 Ordinary Shares in one grant and 50,000 Ordinary Shares in another. Both option series have an exercise price of 29.93 per share and expire in different months of 2032.

What are the vesting terms of Igal Zamir’s TAT Technologies (TATT) options?

One grant vests 37,500 options on March 20, 2026, with 9,375 vesting every three months through March 20, 2029. The other vests 12,500 on August 1, 2026, then 9,375 quarterly through August 1, 2029.

What is the exercise price of the TAT Technologies (TATT) CEO stock options?

Both option grants held by the CEO have an exercise price of 29.93 per share. This price applies to the underlying Ordinary Shares covered by each grant and remains fixed through their respective 2032 expiration dates.

When do Igal Zamir’s TAT Technologies (TATT) options expire?

The 150,000-share option grant expires on March 20, 2032, while the 50,000-share grant expires on August 1, 2032. Both continue vesting in installments until 2029, conditioned on his continued employment.

Are Igal Zamir’s TAT Technologies (TATT) holdings direct or indirect?

All reported holdings are direct. The 21,386 Ordinary Shares and both stock option grants are shown as directly owned, with no indication of trusts, entities, or other indirect ownership structures in the provided data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:07 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zamir Igal

(Last) (First) (Middle)

9335 HARRIS UNIT 260

CORNERS PKWY

(Street)

CHARLOTTE NORTH CAROLINA 28269

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TAT TECHNOLOGIES LTD [ TATT ]

3a. Foreign Trading Symbol
[TATT]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	21,386	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(1)	03/20/2032	Ordinary Shares	150,000	$29.93	D
Stock Options (right to buy)	(2)	08/01/2032	Ordinary Shares	50,000	$29.93	D

Explanation of Responses:

1. The stock options were granted on March 20, 2025. 37,500 options vest on March 20, 2026; and the remaining options vest in installments of 9,375 every three months beginning on June 20, 2026 through March 20, 2029, subject to the Reporting Person's continued employment with the Issuer through each such vesting date.

2. The stock options were granted on August 1, 2025. 12,500 options vest on August 1, 2026; and the remaining options vest in installments of 9,375 every three months beginning on August 1, 2026 through August 1, 2029, subject to the Reporting Person's continued employment with the Issuer through each such vesting date.

	/s/ Igal Zamir	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)